Business Context and Reporting Period
This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp) on July 28, 2023. The registrant is incorporated in Nevada and trades on the Nasdaq Capital Market under the symbol EKSO. The report details a corporate action regarding an equity offering rather than a standard financial reporting period.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the authorization to raise capital:
- Offering Capacity: Up to $5.0 million in common stock.
- Instrument: "At-the-market" offering pursuant to a Sales Agreement with H.C. Wainwright & Co., LLC.
- Underlying Registration: Form S-3 (File No. 333-272607), declared effective on June 20, 2023.
Material Changes
The material change reported is the filing of a Prospectus Supplement on July 28, 2023. This action enables the Company to offer and sell shares of its common stock, par value $0.001 per share, through the designated agent. This supplements the original At the Market Offering Agreement dated October 9, 2020.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the legal validity of the shares to be issued, supported by an opinion from Snell & Wilmer L.L.P. (Exhibit 5.1).
Risks and Contingencies: The document includes a standard disclaimer stating that the report does not constitute an offer to sell or a solicitation of an offer to buy securities in any jurisdiction where such offer would be unlawful prior to registration or qualification.
Investor Verification Checklist
- Verify the current market price of EKSO stock to assess the potential dilution impact of a $5.0 million offering.
- Review the underlying Form S-3 (File No. 333-272607) for the full terms of the offering.
- Confirm the Company's current cash position and liquidity needs to understand the urgency of this capital raise.
- Note that the filing explicitly states no securities are being sold in this specific document; it is a procedural filing to enable future sales.